Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - venlafaxine hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - venlafaxine hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - venlafaxine hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - venlafaxine hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - venlafaxine hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - venlafaxine hydrochloride, quantity: 84.86 mg - capsule, modified release - excipient ingredients: hypromellose; magnesium stearate; sodium lauryl sulfate; ammonio methacrylate copolymer; basic butylated methacrylate copolymer; titanium dioxide; iron oxide red; potable water; gelatin - treatment of major depression, including prevention of relapse and recurrence where appropriate; generalised anxiety disorder; social anxiety disorder; and panic disorder, including prevention of relapse.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - venlafaxine hydrochloride, quantity: 169.71 mg - capsule, modified release - excipient ingredients: magnesium stearate; hypromellose; ammonio methacrylate copolymer; sodium lauryl sulfate; basic butylated methacrylate copolymer; titanium dioxide; indigo carmine; erythrosine; potable water; gelatin - treatment of major depression, including prevention of relapse and recurrence where appropriate; generalised anxiety disorder; social anxiety disorder; and panic disorder, including prevention of relapse.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - desvenlafaxine benzoate, quantity: 146.32 mg (equivalent: desvenlafaxine, qty 100 mg) - tablet, modified release - excipient ingredients: hypromellose; colloidal anhydrous silica; purified talc; microcrystalline cellulose; stearic acid; titanium dioxide; sunset yellow fcf aluminium lake; iron oxide red; polyvinyl alcohol; macrogol 3350 - desvenlafaxine is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine is not indicated for paediatric use.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - desvenlafaxine benzoate, quantity: 73.16 mg (equivalent: desvenlafaxine, qty 50 mg) - tablet, modified release - excipient ingredients: hypromellose; colloidal anhydrous silica; purified talc; microcrystalline cellulose; stearic acid; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - desvenlafaxine is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine is not indicated for paediatric use.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - venlafaxine hydrochloride -